request Request a Protocol
ask Ask a question
Favorite

Indirect immunofluorescence assay was carried out as described previously (68). Briefly, stable U2OS cell lines [KO+ZNF622(wt)-HA, KO+ZNF622(1-359), and KO+ZNF622(109-477)] were infected with HAdV-pVII-Flag (1 FFU/cell) or mock infected (infection medium without virus) for 48 h. Cells were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min and permeabilized with 0.1% Triton X-100 in PBS-T (PBS plus 0.01% Tween 20) for 15 min at room temperature. After blocking the cells with 3% BSA/PBS-T solution, the coverslips were subjected to immunofluorescence analysis using anti-Flag (Sigma, rabbit, 1:1,000) and anti-HA (BioLegend, mouse, 1:1,000) antibodies. Proteins were visualized using anti-mouse IgG(H+L) highly cross-adsorbed secondary antibody, Alexa Fluor 488 (Thermo Fisher Scientific, A-11029, 1:500) and anti-rabbit IgG(H+L) cross-adsorbed secondary antibody, and Alexa Fluor 594 (Thermo Fisher Scientific, A-11012, 1:500) secondary antibodies. Nuclei were counterstained with DAPI (1 μg/ml), and the coverslips were mounted using Fluoromount-G (Southern Biotech) mounting solution. Cells were visualized by a fluorescence microscope (Nikon Eclipse 90i), and the images were processed with NIS-elements (AR 3.10; Nikon) software. Immunofluorescence assays with U2OS cells expressing transfected Myc-NPM1 were performed as described above. Anti-Myc (Sigma, C3956, rabbit, 1:1,000) was used to detect the Myc-NPM1 protein.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A